- Home
- SQFTP vs SNN Comparison
SQFTP vs SNN Comparison
Compare SQFTP & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SQFTP | SNN |
|---|---|---|
| Founded | N/A | 1856 |
| Country | United States | United Kingdom |
| Employees | 15 | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 14.0B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | SQFTP | SNN |
|---|---|---|
| Price | $15.25 | $32.89 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $32.83 |
| AVG Volume (30 Days) | N/A | ★ 496.7K |
| Earning Date | N/A | 03-02-2026 |
| Dividend Yield | N/A | ★ 2.23% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | N/A | ★ 0.56 |
| Revenue | N/A | ★ $5,944,000,000.00 |
| Revenue This Year | N/A | $7.78 |
| Revenue Next Year | N/A | $5.13 |
| P/E Ratio | ★ N/A | $28.55 |
| Revenue Growth | N/A | ★ 5.35 |
| 52 Week Low | N/A | $23.69 |
| 52 Week High | N/A | $38.79 |
Technical Indicators
Market Signals| Indicator | SQFTP | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 39.72 | 46.72 |
| Support Level | $15.50 | $32.06 |
| Resistance Level | $15.80 | $33.60 |
| Average True Range (ATR) | 0.19 | 0.43 |
| MACD | -0.07 | 0.07 |
| Stochastic Oscillator | 0.00 | 44.86 |
Price Performance
Historical ComparisonAbout SQFTP Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.